Collateral License Agreement between GeneLink, Inc. and The University of North Texas Health Science Center at Forth Worth dated July 1, 1996. 2 pages
The New Hampshire Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding agreement that outlines the terms and conditions for the licensing of certain collateral assets to support research and development activities. This agreement is specifically tailored to the partnership between Gentling, Inc. and The University of North Texas Health Science Center in New Hampshire. Keywords: New Hampshire, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, licensing, collateral assets, research and development, partnership. This Collateral License Agreement is designed to protect the interests of both parties involved by clearly defining the rights and responsibilities related to the collateral assets provided by Gentling, Inc. to The University of North Texas Health Science Center. The agreement ensures that the collateral assets are used solely for the purposes of research and development activities conducted by The University of North Texas Health Science Center. By entering into this agreement, Gentling, Inc. grants The University of North Texas Health Science Center a non-exclusive license to use the collateral assets, including but not limited to laboratory equipment, software, and data. This license allows the university to utilize the collateral assets for research projects, experiments, and other scientific endeavors related to their field of study. In return for the license, The University of North Texas Health Science Center agrees to handle the collateral assets with care and maintain them in good condition. They are responsible for any damage or loss that may occur while the assets are under their possession. Additionally, the university agrees to use the collateral assets strictly in accordance with applicable laws and regulations. Moreover, this agreement outlines the terms for termination, indemnification, and dispute resolution. It specifies the rights of each party in case of termination and establishes the procedures for resolving any disagreements or disputes that may arise throughout the course of the collaboration. Different types of New Hampshire Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center could include variations in licensing terms, scope of collateral assets, and specific research areas involved. These customizations are made to accommodate the unique requirements and objectives of different research projects or collaborations between the two entities. In summary, the New Hampshire Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document that ensures the proper licensing and usage of collateral assets for research and development activities. The agreement protects the interests of both parties and facilitates a mutually beneficial partnership in advancing scientific knowledge and innovation.
The New Hampshire Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a legally binding agreement that outlines the terms and conditions for the licensing of certain collateral assets to support research and development activities. This agreement is specifically tailored to the partnership between Gentling, Inc. and The University of North Texas Health Science Center in New Hampshire. Keywords: New Hampshire, Collateral License Agreement, Gentling, Inc., The University of North Texas Health Science Center, licensing, collateral assets, research and development, partnership. This Collateral License Agreement is designed to protect the interests of both parties involved by clearly defining the rights and responsibilities related to the collateral assets provided by Gentling, Inc. to The University of North Texas Health Science Center. The agreement ensures that the collateral assets are used solely for the purposes of research and development activities conducted by The University of North Texas Health Science Center. By entering into this agreement, Gentling, Inc. grants The University of North Texas Health Science Center a non-exclusive license to use the collateral assets, including but not limited to laboratory equipment, software, and data. This license allows the university to utilize the collateral assets for research projects, experiments, and other scientific endeavors related to their field of study. In return for the license, The University of North Texas Health Science Center agrees to handle the collateral assets with care and maintain them in good condition. They are responsible for any damage or loss that may occur while the assets are under their possession. Additionally, the university agrees to use the collateral assets strictly in accordance with applicable laws and regulations. Moreover, this agreement outlines the terms for termination, indemnification, and dispute resolution. It specifies the rights of each party in case of termination and establishes the procedures for resolving any disagreements or disputes that may arise throughout the course of the collaboration. Different types of New Hampshire Collateral License Agreements between Gentling, Inc. and The University of North Texas Health Science Center could include variations in licensing terms, scope of collateral assets, and specific research areas involved. These customizations are made to accommodate the unique requirements and objectives of different research projects or collaborations between the two entities. In summary, the New Hampshire Collateral License Agreement between Gentling, Inc. and The University of North Texas Health Science Center is a comprehensive legal document that ensures the proper licensing and usage of collateral assets for research and development activities. The agreement protects the interests of both parties and facilitates a mutually beneficial partnership in advancing scientific knowledge and innovation.